Laser trabeculoplasty trends with the introduction of new medical treatments and selective laser trabeculoplasty

Journal of Glaucoma

Volumn 15, Issue 4, 2006, Pages 306-309

  Rachmiel, Rony ^a   Trope, Graham E ^a   Chipman, Mary L ^a,b   Gouws, Peter ^a   Buys, Yvonne M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Glaucoma; Laser trabeculoplasties; Medications; SLT

Indexed keywords

BIMATOPROST; BRIMONIDINE; BRIMONIDINE PLUS TIMOLOL MALEATE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

ARTICLE; CANADA; CONTROLLED STUDY; CORRELATION ANALYSIS; GLAUCOMA; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELECTIVE LASER TRABECULOPLASTY; TRABECULOPLASTY;

ADULT; ANTIHYPERTENSIVE AGENTS; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; ONTARIO; PREVALENCE; RETROSPECTIVE STUDIES; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 33746433466     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000212233.11287.b3     Document Type: Article

References (37)

1. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Arch Ophthalmol. 1979;97:319-322.
2. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow up Study 7. Results. Am J Ophthalmol. 1995;120:718-731.
3. Glaucoma Laser Trial Research Group. The glaucoma Laser Trial (GLT): 2. Results of argon laser trabeculoplasty vs topical medicines. Ophthalmology. 1990;11:1403-1413.
4. Dielemans I, Vingerling JR, Wolfs RCW, et al. The prevalence of glaucoma in a population-based study in the Netherlands: the Rotterdam study. Ophthalmology. 2004;101:1851-1855.
5. Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol. 2002;86:551-554.
6. Bateman DN, Clark R, Azuara-Blanco A, et al. The impact of new drugs on management of glaucoma in Scotland: observational study. BMJ. 2001;323:1401-1402.
7. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare Population from 1995 to 1998. Ophthalmology. 2002;109:1372-1376.
8. Baduoin C, Rouland JF, Le Pen C. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol. 2003;13(Suppl 4):S53-S60.
9. Walland MJ. Glaucoma treatment in Australia: changing patterns of therapy 1994-2003. Clin Exp Ophthalmol. 2004;32:590-596.
10. Whittaker KW, Gillow JT, Cunliffe IA. Is the role of trabeculectomy in glaucoma management changing? Eye. 2001;15(Part 4):449-452.
11. Latina NA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd: Yag laser trabeculoplasty (selective laser tabeculoplasty). Ophthalmology. 1998;105:2082-2090.
12. Anderson RR, Parish HA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-547.
13. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995;60:359-371.
14. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eye. Ophthalmology. 2001;108:773-779.
15. Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty Vs argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol. 1999;83:718-722.
16. Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open angle glaucoma. Ophthalmology. 2004;111:853-1859.
17. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation and postoperative pain. Eye. 2004;18:498-502.
18. Lai JS, Chua JK, Tham CC, et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Exp Ophthalmol. 2004;32:368-372.
19. Melamed S, Ben-Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma. Arch Ophthalmol 2003;121:957-960.
20. Huck AH, Michele CL. Glaucoma lasers: a review of the newer techniques. Curr Opin Ophthalmol. 2005;16:89-93.
21. Statistics Canada. Annual demographic statistics: population estimates by age and sex, Canada, provinces and territories, 2001-2003 (including all components of demographic growth) [computer file]./Principal investigator: Statistics Canada. Ottawa, Ont. Statistics. Canada [producer]; Communications Canada. Depository Services Program [distributor], March 8, 2004 (Statistics Canada, cat. no. 91-213) http://www.library.utoronto.ca/datalib/datar/cstdsp/91- 213-xpb/2003/provter/as/inter/as0103.xls.
22. Tuck MW, Pitts Crick R. The projected increase in glaucoma due to an ageing population. Ophthal Physiol Opt. 2003;23:75-179.
23. Tuck MW, Crick RP. The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 1998;5:173-183.
24. Minassian DC, Reidy A, Coffet M, et al. Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK. Br J Ophthalmol. 2000;84:1159-1161.
25. Leske M, Connell A, Schachat A, Hyman L. The Barbados Eye Study: prevalence of open-angle glaucoma. Arch Ophthalmol. 1994;112:821-829.
26. Tielsh J, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266:369-374.
27. Klein BEK, Klein R, Sponsel W, et al. Prevalence of glaucoma: the Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.
28. Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. Ophthalmology. 1996;103:1661-1669.
29. Dielemans I, Vingerling JR, Wolfs RCW, et al. The prevalence of glaucoma in a population-based study in The Netherlands: The Rotterdam study. Ophthalmology. 1994;101:1851-1855.
30. Coffey M, Reidy A, Wormald R, et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol. 1993;77:17-21.
31. Giuffre G, Giammanco R, Dardanoni G, et al. Prevalence of glaucoma and distribution of intraocular pressure in a population. The Casteldaccia Eye Study. Acta Ophthalmol. 1995;73:222-225.
32. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population population: the Egna-Neumarkt Study. Ophthalmology. 1998;105:733-739.
33. Weih LM, Nanjan M, McCarty CA, et al. Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology. 2001;108:1966-1972.
34. Reidy A, Minassian DC, Vafidis G, et al. Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study. North London. BMJ. 1998;316:1643-1646.
35. Dueker DK, Norberg M, Johnson DH, et al. Stimulation of cell division by Argon and Nd: YAG laser trabeculoplasty in Cynomolgus monkeys. Invest Ophthalmol Vis Sci. 1990;31:115-124.
36. Shingleton BJ, Richter CU, Dharma SK, et al. Long term efficacy of argon laser trabeculoplasty. Ophthalmology. 1987;94:1513-1518.
37. Albright CD, Schuman SG, Netland PA. Usage and cost of laser trabeculoplasty in the United states. Ophthalmic Surg Lasers. 2002;33:334-336.